Drugmakers are increasingly using the media to tout coronavirus treatments that are still under review. Call it science by press release.
Vaccine maker Moderna attracted glowing headlines and bullish investors when it revealed that eight participants in a preliminary clinical trial of its coronavirus vaccine had developed antibodies to the virus. The company’s share price jumped nearly 20 percent that day as it released a massive stock offering.
The Food and Drug Administration authorized emergency use of the malaria drug hydroxychloroquine in March without any proof that it was safe or effective for coronavirus patients — but with the backing of President Donald Trump, who had begun touting the treatment during daily White House briefings. But observers aren’t so sure. “From the outside looking in, there seems to be more political pressure than ever,” said Marc Scheineson, a former associate commissioner at the FDA and head of the FDA group at Alston & Bird. “The example in the White House is trickling down and there is a lot of pressure on the FDA … to color information on the optimistic side for political purposes and that is a hugely disturbing trend.
Other groups have also previewed their hotly anticipated vaccine studies in the press. In late April, The New York Times revealed that six monkeys given a vaccine developed by researchers at the U.K.’s University of Oxford had stayed healthy for 28 days despite sustained exposure to the coronavirus. The article quoted Vincent Munster, a researcher at the NIH’s Rocky Mountain Laboratory, which conducted the monkey study at the British scientists’ behest.
Liz Derow, a spokesperson for Oxford’s Jenner Institute, where the vaccine researchers are based, said they did not give the monkey data to The New York Times. The NIH’s National Institute of Allergy and Infectious Disease, which operates the Rocky Mountain Laboratory, said it did not provide the data to the newspaper — but one of its researchers, Vincent Munster, spoke to a Times reporter about the monkey findings at the request of the Jenner Institute.
Neither the Oxford nor Moderna vaccines are available to the public. But some drugs whose safety and efficacy are now being studied have already been repurposed or authorized for emergency use during the pandemic. The rush to release snippets of information on drug trials to the press ahead of full results has left some doctors wondering how to best treat their patients.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
LA Galaxy Call Meeting with Player Over Wife's 'Racist and Violent' Social Media PostsThe posts included a call to 'kill' protesters and were condemned by both the team and her husband.
続きを読む »
Philadelphia Inquirer journalists call out sick after paper publishes the headline: 'Buildings Matter, Too'A large contingent of journalists at the Philadelphia Inquirer took a sick day Thursday to demand change at the newspaper, in the wake of the paper's decision to print an article headlined 'Buildings Matter, Too'
続きを読む »
On Breonna Taylor's Birthday, People Call for Justice with Birthday CardsWriter and critic battymamzelle created the campaign BirthdayForBreonna for supporters to write to government officials with demands of justice for her death.
続きを読む »
Because of COVID-19 pandemic Navy to start 'safe haven' ports of call for its shipsIn an effort to keep a 'COVID-free bubble' for its sailors at sea during the pandemic, the Navy will only allow ports of call at a select number of Navy bases around the world that will serve as 'safe havens.'
続きを読む »
Looking Back on Hollywood's Pioneering LGBTQ Collective: 'They'd Call Us the Lavender Mafia'Producers Nina Jacobson and Bruce Cohen reflect on the trailblazing 'Out There' alliance they founded in 1995 that paved the way for gay activism in Hollywood.
続きを読む »